Neuroone Medical Technologies NMTC
NASDAQ NMTC
$1.12 +0.13 (+13.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neuroone Medical Technologies (NMTC) Return on Sales [ROS] (2011 - 2026)

Updated

Neuroone Medical Technologies (NMTC) reported Return on Sales [ROS] of -122.87% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 11.63 percentage points from -111.23% a year earlier but up 5.87 percentage points from the prior quarter.

Analysis

Neuroone Medical Technologies (NMTC) Return on Sales [ROS] (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Neuroone Medical Technologies' Return on Sales [ROS] came in at -83.43%, up 2.13 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at -46.46%, up 297.80 percentage points from FY2024.

  • Return on Sales [ROS] has increased for three consecutive fiscal years, with a four-year change of +5689.41 percentage points (FY2021 to FY2025).
  • By fiscal year, Return on Sales [ROS] came in at -344.26% in FY2024 (+268.07 pp), -612.32% in FY2023 (+5247.83 pp), -5860.15% in FY2022 (-124.29 pp) and -5735.86% in FY2021.
  • Five-year quarterly Return on Sales [ROS] spans a low of -8616.29% in fiscal Q3 2022 and a high of 52.26% in fiscal Q1 2025.
  • Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of +120.08 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was fiscal Q3 2023 (a gain of 8059.02 percentage points); the low point was fiscal Q1 2022 (a drop of 5325.57 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -128.74% (Q2 2026), -59.02% (Q1 2026) and -50.02% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 Neuroone Medical Technologies 9.75 Mn -5.27 Mn 1.18 Mn -122.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -122.87%
Mar 31, 2026 -128.74%
Dec 31, 2025 -59.02%
Sep 30, 2025 -50.02%
Jun 30, 2025 -111.23%
Mar 31, 2025 -193.29%
Dec 31, 2024 52.26%
Sep 30, 2024 -1,034.48%
Jun 30, 2024 -338.34%
Mar 31, 2024 -209.55%
Dec 31, 2023 -346.80%
Sep 30, 2023 -426.64%
Jun 30, 2023 -557.26%
Mar 31, 2023 -749.91%
Dec 31, 2022 -1,557.31%
Sep 30, 2022 -2,035.52%
Jun 30, 2022 -8,616.29%
Mar 31, 2022 -8,363.79%
Dec 31, 2021 -8,324.42%
Sep 30, 2021 -5,470.30%
API Access

Neuroone Medical Technologies Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NMTC&period=max&api_key=YOUR_API_KEY